Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 16/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.33 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19937851 | 0.95 | MAP3K12 (0.51) | MAP3K12FGFR1FGFR2FGFR3CRHR1 | |
| SCHEMBL19937631 | 0.81 | MAP3K12 (0.54) | MAP3K12 | |
| SCHEMBL19937987 | 0.81 | MAP3K12 (0.56) | MAP3K12 | |
| SCHEMBL19937617 | 0.79 | MAP3K12 (0.50) | MAP3K12FGFR1FGFR2FGFR3CRHR1 | |
| SCHEMBL19937643 | 0.79 | MAP3K12 (0.50) | MAP3K12FGFR1FGFR2FGFR3 | |
| SCHEMBL19937663 | 0.77 | MAP3K12 (0.50) | MAP3K12 | |
| SCHEMBL19937997 | 0.76 | MAP3K12 (0.52) | MAP3K12FGFR1FGFR2FGFR3 | |
| SCHEMBL19937780 | 0.76 | MAP3K12 (0.52) | MAP3K12FGFR1FGFR2FGFR3CRHR1 | |
| SCHEMBL19937665 | 0.76 | MAP3K12 (0.52) | MAP3K12 | |
| SCHEMBL19937750 | 0.76 | MAP3K12 (0.55) | MAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2945938-B1 | 3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS | HOFFMANN LA ROCHE (CH) | 2018-03-07 | — | — | EP | disclosed |